Randomized trial: Neutralizing monoclonal antibody not efficacious among hospitalized patients with covid-19

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 – New England Journal of Medicine

Commentaries: Covid-19: Trial of LY-CoV555 Stopped for Futility – Physician’s Weekly AND Results of NIH-sponsored ACTIV-3 trial published – NIH News Releases AND Bamlanivimab Flops in Hospitalized COVID-19 Patients – MedPage Today (free registration required)